In this study, it was hypothesized that progesterone (P4) acts as a survival factor primarily by actions of the classic nuclear progesterone receptor (PGR) signaling pathway in rat periovulatory granulosa cells. Granulosa cells were isolated from immature female rats primed with equine chorionic gonadotropin/human chorionic gonadotropin and treated in vitro with PGR antagonists. As little as 10 nM of two different PGR antagonists (Org 31710 and RU 486) increased apoptosis measured as caspase 3/7 activity, which was reversed by cotreatment with the progestin R5020. Concurrently, P4 synthesis was decreased. Inhibition of P4 synthesis by cyanoketone similarly induced apoptosis but required greater inhibition of P4 synthesis than that seen after treatment with PGR antagonists. Therefore, the induction of apoptosis by PGR antagonists cannot be explained by decreased P4 synthesis alone. Low concentrations of R5020 also completely reversed the effects of cyanoketone. Inhibition of P4 synthesis was more effective in inducing apoptosis than treatment with PGR antagonists. However, cotreatment with PGR antagonists protected cells from the additional effects of cyanoketone, indicating partial agonist effects of the antagonists and a dominating role for PGR in P4-mediated regulation of apoptosis. Progesterone receptor membrane component 1 (PGRMC1) was expressed in granulosa cells; however, an anti-PGRMC1 antibody did not induce apoptosis in periovulatory granulosa cells. Neither anti-PGRMC1 nor P4 or cyanoketone affected apoptosis of immature granulosa cells. In conclusion, we show that P4 regulates apoptosis in periovulatory granulosa cells by acting via the classic nuclear receptor.
INTRODUCTION
Progesterone (P4) is best known as a hormone produced by the corpus luteum and the placenta, with the main function to prepare the uterine endometrium for implantation of a fertilized oocyte and to maintain pregnancy. However, P4 is also involved in ovulation and luteinization of the postovulatory follicle. Working in an autocrine/paracrine manner, P4 takes on an orchestrating role in the transcriptional changes of the luteinizing granulosa cells after the ovulation-inducing surge of luteinizing hormone (LH) [1] .
During follicular development, granulosa cells are subjected to strong selective pressure based on apoptosis, ultimately leading to atresia of more than 99.9% of all growing follicles [2] [3] [4] . Many factors take part in the regulation of proliferation and apoptosis of granulosa cells. Progesterone is one of several factors that have an antiapoptotic role in the regulation of granulosa and luteal cell survival in most species studied [5] [6] [7] [8] [9] [10] . Traditionally, P4 was thought to mediate all of its effects via the nuclear progesterone receptor (PGR). Expression of PGR in granulosa cells is induced transiently by LH in rodents [8, 11, 12] , in contrast to humans, in whom PGR remains expressed in the corpus luteum [13, 14] . However, rapid action of P4 in sperm activation, for example, has led to the identification of several other candidate progesterone receptors or receptor groups mediating cellular actions in a nongenomic manner [15, 16] .
The involvement of the classic PGR in apoptosis regulation of granulosa cells has previously been studied by our group [6, 8, [17] [18] [19] [20] and by others [5, 7, 9] . However, the biological relevance of previous studies using PGR antagonists is controversial because the antagonist concentrations used were several potencies higher than the local concentration of P4 [21] . Indeed, because high concentrations of PGR antagonists decrease P4 synthesis [20] , it has been suggested that the apoptotic effects of specific PGR antagonists could be an indirect effect mediated via decreased stimulation of other progesterone receptors [21] .
Most important, P4 has been implicated in apoptosis regulation in several stages of granulosa cell development, including early preovulatory granulosa cells lacking expression of PGR [22] . The effects of P4 in cells lacking PGR could be attributed to recently characterized membrane progestin receptors or binding proteins. One group of proteins reported to function in rapid membrane-initiated P4 signaling has been studied by Engmann et al. [21] , by Peluso et al. [23] [24] [25] , and by Lösel et al. [26] . In granulosa cells, these proteins (termed progesterone receptor membrane component 1 [PGRMC1] and serpine1 mRNA-binding protein 1 [SERBP1]) interact as a functional complex binding P4 [23, 24] . Several studies report that these proteins are involved in the regulation of apoptosis in early differentiated granulosa cells, mainly based on experiments with spontaneously immortalized rat granulosa cells (SIGCs) [23] [24] [25] and with luteinized human granulosa cells [21] .
Progesterone is well established as a survival factor in granulosa cells. However, the mechanism by which P4 acts to inhibit apoptosis of periovulatory granulosa cells is still controversial. This controversy warrants a careful investigation of the involvement of PGR. It is hypothesized that PGR is involved in apoptosis regulation of rat periovulatory granulosa cells and furthermore that this involvement cannot be attributed to mediatory roles of other P4 signaling systems. This study was designed 1) to examine the dose-dependency and specificity of effects of PGR antagonists on apoptosis in vitro in primary periovulatory granulosa cells and 2) to relate the effects of PGR antagonists to other possible pathways mediating effects of P4.
MATERIALS AND METHODS

Animals
Immature female rats (20-day-old Sprague-Dawley) were purchased from B&K Universal, Sollentuna, Sweden, or from Taconic, Ejby, Denmark. After arrival, the animals were acclimatized for 6 days before onset of experiments. The rats were given free access to food and water and were kept in a controlled environment with a 12L:12D photoperiod. All animal experiments were approved by the local animal ethics committee in Gothenburg, Sweden.
Granulosa Cell Isolation
At age 26 days, rats were injected s.c. with equine chorionic gonatrotropin (eCG) (10 IU; Sigma, St. Louis, MO) to induce follicle growth and development. After 48 h, an i.p. injection of human chorionic gonatrotropin (hCG) (50 IU; Organon, Oss, the Netherlands) was given to induce luteinization of preovulatory follicles according to previously established protocols [6, 17, 19] . A subset of rats was used as untreated immature controls. The rats were killed by cervical dislocation 7 h after hCG treatment, ovaries were isolated, and granulosa cells were collected by follicle puncture. The granulosa cell isolation time was chosen to approximately match the peak expression of PGR [8, 11] . Responding follicles were selected based on the degree of vascularization and size. Isolation of granulosa cells was done in minimum essential medium (MEM) with Earle salts and L-glutamine (Invitrogen, Carlsbad, CA) supplemented with sodium hydrogen carbonate (0.0375% [w/v]). Cells were pelleted by centrifugation for 5 min at 200 3 g, resuspended in Eagle MEM with GlutaMAX-I, Earle salts, and Hepes (Invitrogen) supplemented with penicillin (100 IU/ml; Invitrogen), streptomycin (100 lg/ml; Invitrogen), and bovine serum albumin (BSA) fraction V (0.1%; Sigma) and counted in a Bürker chamber after trypan blue staining.
Granulosa Cell Incubation
Isolated granulosa cells were incubated in Eagle MEM (supplemented as already described) with 10 6 cells/ml in 0.5 or 1.0 ml in culture tubes (Falcon 12 3 75 mm; Becton Dickinson, NJ) for P4 assay and immunoblotting purposes or with 20 000 cells in 100 ll in 96-well plates (96F Nuclon delta white microwell S1; Nunc, Roskilde, Denmark) for caspase activity assays. The incubations were carried out with or without addition of the nuclear PGR antagonist Org 31710 (10 nM to 10 lM; Organon) or RU 486 (10 nM to 10 lM; Exelgyn, Paris, France), the progestin R5020 (1 nM to 1 lM; Perkin Elmer, Waltham, MA), P4 (10 nM to 1 lM; Sigma), the irreversible hydroxy-delta-5-steroid dehydrogenase 3-beta and steroid delta-isomerase cluster (HSD3B) inhibitor cyanoketone (3 nM to 1 lM; Sterling Drugs Inc., Rensselaer, NY), or antibodies against PGRMC1 (1-50 lg/ml, kindly provided by Ralf Lösel, Department of Clinical Pharmacology, University of Heidelberg, Mennheim, Germany) [27] . Cyanoketone was dissolved as a stock solution in dimethyl sulfoxide, whereas all other drugs were dissolved as stock solutions in ethanol, and the lyophilized PGRMC1 antibody was diluted directly in culture medium. The final concentration of solvent in the incubation medium did not exceed 0.1%, and this concentration had no effect on the measured variables (data not shown). Incubations were carried out at 378C in 5% CO 2 and 95% humidified air for 22 h. Serum-free incubation is commonly used to induce apoptosis in isolated granulosa cells [28] . The periovulatory interval is defined as the time from the onset of LH surge or hCG administration to follicle rupture [1] . Herein, we use the term periovulatory for preovulatory granulosa cells isolated from eCG/hCG primed immature rats and cultured in vitro for up to 22 h [6, 17, 19] .
Apoptosis Measurements
Caspase 3/7 activity was measured using the Caspase-Glo 3/7 assay kit (Promega, Madison, WI) according to the manufacturer's instructions. The assay is based on the cleavage of a proluminescent caspase substrate containing the tetrapeptide sequence DEVD. The amount of luminescent product generated is proportional to the caspase 3/7 activity in the sample. Luminescence was detected 30 min after addition of substrate using a Fluostar plate reader (BMG Labtechnologies, Offenburg, Germany).
P4 Measurements
P4 in spent medium was analyzed using dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA) [29] (Perkin Elmer, Å bo, Finland). The measurements were performed according to the manufacturer's instructions.
Immunoblot Analysis
After incubation, cells to be used for immunoblotting were pelleted at 10 000 3 g at 48C, and the pellets were washed in ice-cold PBS and frozen at À708C. Intact ovaries were washed in PBS and were snap frozen in liquid nitrogen immediately after dissection. Cells and tissues were homogenized at 48C in lysing buffer (ristocetin-induced platelet agglutination buffer) (150 mM NaCl, 50 mM Tris-HCl [pH 7.5], 1 mM edetic acid, 1 mM NaF, 1% Nonidet P-40, 10 lg/ml of phenylmethylsulfonyl fluoride, 1 mM Na 3 VO 4 , and a cocktail of protease inhibitors [Roche Diagnostics GmbH, Mannheim, Germany]) and were incubated on ice for 30 min. Subsequently, insoluble material was removed by centrifugation at 10 000 3 g for 30 min at 48C. The protein content of the extracts was determined using a bicinchoninic acid protein assay (Pierce, Rockford, IL), with BSA as the standard. Thirty micrograms of protein per sample was heated at 708C for 10 min with reducing agents and loaded onto 4%-12% Bis-Tris gels (Novex, San Diego, CA) using a 3-(N-morpholino) propanesulfonic acid (MOPS)-SDS running system. Nonspecific protein binding to the polyvinylidene difluoride membranes (Amersham International, Buckinghamshire, England) was prevented by preincubation of the membrane with 5% nonfat milk in a Tris-buffered saline-Tween 20 buffer (10 mM Tris, 150 mM NaCl, and 0.1% Tween 20 [pH 8.0]) for 2 h. Antibodies against PGRMC1 were provided as lyophilized serum. The PGRMC1 antibody is a rabbit polyclonal antibody directed against 15 N-terminal amino acids of porcine PGRMC1 [27] . This sequence is identical in porcine, human, and rat PGRMC1. The membranes were incubated with primary antibody at a dilution of 1:1000 in blocking buffer overnight at 48C, followed by incubation with the appropriate goat anti-rabbit alkaline phosphatase-linked secondary antibody (Tropix, Bedford, MA) at a 1:40 000 (v/v) dilution for 2 h. The immunosignal CDP-Star substrate for the alkaline phosphatase system (Tropix) was used to visualize protein bands. The ECL films of the Western blots were captured using an image scanner (Perfection 2450 photo scanner; Epson American Inc., Long Beach, CA). All steps were carried out at room temperature unless otherwise stated.
Statistical Analysis
All quantitative experiments were performed at least three times, typically with samples numbers of 6-8 for each treatment in each experiment. Combined data from multiple experiments are presented graphically as normalized to the control group in each experiment unless stated otherwise. All statistical analyses were performed using SPSS statistical software (version 15; SPSS Inc., Chicago, IL). Differences between group means were analyzed using the univariate general linear model and included terms for treatment and experiment. Post hoc tests were applied where appropriate, including Dunnett test for multiple comparisons to a control or Bonferroni test for comparisons between groups. Single-sided or double-sided tests were used where appropriate based on hypotheses and indications from previous data. Residual analyses were used to check assumptions of normality and equality of variances. Data were transformed into natural logarithms as appropriate after residual analyses. The caspase activity assays used herein occasionally result in outlier values due to cell clumping and well debris. Outliers were therefore detected and omitted objectively based on studentized residuals with P , 0.01 [30] . Data are presented as mean 6 SEM. P , 0.05 was considered statistically significant.
RESULTS
PGR Antagonists Org 31710 and RU 486 Induce Apoptosis
To characterize the importance of PGR in granulosa cell apoptosis, cells were isolated from eCG-and hCG-primed immature rats 7 h after hCG injection. The selective PGR antagonist Org 31710 and the more commonly used RU 486 PROGESTERONE CONTROL OF GRANULOSA CELL APOPTOSIS were used to block cellular effects mediated via PGR. Both antagonists in a dose-dependent manner induced apoptosis as measured by caspase 3/7 activity assay (Fig. 1, A and B) . The lowest effective concentration tested was 10 nM (P , 0.01) for both antagonists. The caspase activity reached an apparent plateau at an approximate 22%-32% increase compared with controls at concentrations of antagonists ranging from 10 to 30 nM to 1000 to 3000 nM. However, higher micromolar concentrations resulted in a second, much more potent increase in caspase activity. To verify that the cause of the induced caspase activity at nanomolar concentrations of antagonists was competitive antagonism of PGR, granulosa cells were cotreated with Org 31710 and R5020 (Promegestone; Perkin Elmer). Increasing concentrations of R5020 completely reversed apoptosis induced by Org 31710 (100 nM) (Fig. 1C) . In contrast, the increase in apoptosis resulting from Org 31710 at concentrations above 1 lM could not be reversed by R5020 (data not shown). By itself, R5020 significantly reduced caspase activity to 86% of control levels (P , 0.001) (Fig. 2) .
Inhibition of P4 Synthesis Increases Apoptosis
It has been suggested that P4 may control its synthesis by regulating the activity of steroidogenic enzymes [31] [32] [33] . Accumulation of P4 after culturing cells for 22 h was therefore measured. Treatment of granulosa cells with Org 31710 (100 nM) significantly decreased the amount of P4 to approximately 76% of control levels in spent medium, from 51.0 6 1.2 nM to 39.00 6 0.75 nM (P , 0.001). It has also been suggested that PGR antagonists could induce apoptosis indirectly by their ability to decrease P4 synthesis [21] . If alternative progesterone receptors are involved and have a mediatory role, they would be dependent on the availability of the ligand. To investigate if this inhibition of P4 synthesis resulting from Org 31710 treatment could explain the increase in apoptosis, granulosa cells were treated with the irreversible HSD3B inhibitor cyanoketone. As expected, cyanoketone decreased P4 accumulation in a dose-dependent manner, with a consistent significant effect at a lowest concentration of 10 nM (Fig.  3A) . Treatment with cyanoketone concurrently induced apoptosis (Fig. 3B) . The lowest effective concentration was 3 nM (P , 0.001), which increased apoptosis by 5.1%. At a 
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concentration of 30 nM, the degree of apoptosis induced was comparable to that of PGR antagonists at 100 nM. Because inhibition of HSD3B has broad effects on general steroid synthesis, granulosa cells were cotreated with cyanoketone and R5020 to determine if the effects were caused by decreased P4 synthesis specifically. The increase in caspase activity induced by cyanoketone (1000 nM) was completely reversible by R5020 (5 nM) (Fig. 3C) .
PGR Antagonists Protect Cells from the Effects of Cyanoketone
It can be assumed that removal of P4 should have the same effect on induction of apoptosis as treatment with PGR antagonists provided that P4 regulates apoptosis solely via the actions of PGR. To determine whether cyanoketone has additional effects compared with those of Org 31710, a set of experiments was carried out to compare the treatments. Indeed, the effect of cyanoketone was significantly greater than the effects of Org 31710 and RU 486 (Fig. 4) . However, when granulosa cells were cotreated with cyanoketone and Org 31710 or RU 486, the additional effect of cyanoketone was abolished, implying that these PGR antagonists can protect the cells from cyanoketone-induced apoptosis.
Blocking Antibody Against PGRMC1 Does Not Induce Apoptosis
Studies in rat and human granulosa and luteal cells suggest an involvement of PGRMC1 and SERBP1 in apoptosis regulation by P4 [21, [23] [24] [25] . Antibodies against PGRMC1 have been shown to block the antiapoptotic effects of P4 in rat SIGCs and human luteal cells [21, 24] . Therefore, to investigate the involvement of PGRMC1 in rat periovulatory granulosa cells, Western blotting was performed to determine the presence of PGRMC1 in granulosa cell cultures and to confirm the integrity of the antibody (Fig. 5A) . A clear band of approximately 26 kDa was detected in isolated periovulatory granulosa cells and in whole ovary. To test if PGRMC1 is involved in the control of apoptosis induction in periovulatory rat granulosa cells, anti-PGRMC1 antibodies were included in the culture medium. None of the concentrations used resulted in increased caspase activity (Fig. 5B) . In contrast, there was a significant decrease in apoptosis in cells treated with antibodies and in cells treated with dilutions of preimmunized rabbit serum (data not shown), which indicates an unspecific beneficial effect of serum on cell survival.
To validate the blocking activity of the anti-PGRMC1 antibody, its effect on immature granulosa cells was investigated. In contrast to previously published data [21, 24] , inclusion of anti-PGRMC1 suppressed rather than induced apoptosis, regardless of the presence of exogenous P4 in the medium (Fig. 5C) . A similar dose-dependent decrease in caspase activity was seen after treatment with preimmunized rabbit serum in immature cells (data not shown). Because anti-PGRMC1 has been described as only reversing an antiapoptotic effect of P4 [21, 24] , the effect of P4 on immature granulosa cells was investigated. In contrast to previously published data [34, 35] , P4 (10-1000 nM) had no beneficial effect on the survival of immature granulosa cells (Fig. 5D) . To investigate if the lack of effect of added P4 was due to low intrinsic production of P4, the effect of cyanoketone (1 lM) was determined. Cyanoketone did not affect the degree of apoptosis, nor was it affected by addition of P4 (Fig. 5E ). To control for the possible presence of PGR or unspecific effects of Org 31710, immature granulosa cells were treated with 100 nM or 10 lM Org 31710. As expected, the low concentration of Org 31710 had no effect on caspase activity, while the high concentration significantly induced apoptosis.
DISCUSSION
In this study, it was hypothesized that PGR is involved in regulating rat periovulatory granulosa cell apoptosis. The results presented demonstrate that PGR antagonists specifically and reversibly induce apoptosis without involving other possible signaling pathways of P4. No support for the involvement of the proposed P4-binding protein PGRMC1 was found.
RU 486 is a well-characterized antiprogestin that also possesses antiglucocorticoid actions [36] , whereas Org 31710 is more specific for PGR [37] . Both antagonists have been previously used to study granulosa cell apoptosis [6, 7, 20, 34] . However, the physiological relevance of previous findings have been questioned because the concentrations used were in the micromolar range [21] .
The expression of Pgr in cultured periovulatory granulosa cells has been examined using microarrays and real-time PCR (Friberg et al., unpublished results) . A high level of Pgr mRNA is present at the beginning of culture, but the level declines sharply after 22 h. In addition, Org 31710 causes a slight but 
FIG. 5. A)
Immunoblot using a polyclonal antibody against PGRMC1 in periovulatory rat granulosa cells (GC) or intact ovaries (Ov). Values are given as kilodaltons. B) Effect of antibodies against PGRMC1 on apoptosis measured as caspase 3/7 activity in rat periovulatory granulosa cells. The concentration refers to the weight of the lyophilized serum pellet dissolved in the original volume. General linear model, followed by double-sided Dunnett post hoc test. C) Effect of P4 and/or anti-PGRMC1 antibody on apoptosis measured as caspase 3/7 activity in immature rat granulosa cells. General linear model, followed by double-sided Dunnett post hoc test. D) Effect of P4 on apoptosis measured as caspase 3/7 activity in immature rat granulosa cells. General linear model, followed by singlesided Dunnett post hoc test. E) Effect of P4 and/or HSD3B inhibitor cyanoketone (Cyk) on apoptosis measured as caspase 3/7 activity in immature rat granulosa cells. General linear model, followed by singlesided Dunnett post hoc test. F) Effect of PGR antagonist Org 31710 on apoptosis measured as caspase 3/7 activity in immature rat granulosa cells. General linear model, followed by single-sided Dunnett post hoc test. Bars represent mean 6 SEM. *P , 0.05, **P , 0.01, ***P , 0.001; NS, not significant. 1164 significant suppression of Pgr mRNA early in the culture. Herein, Org 31710 and RU 486 were applied in a wide range of concentrations to examine if PGR has a physiologically plausible role in apoptosis regulation. Low concentrations of PGR antagonists, comparable to the culture levels of P4 (approximately 35-50 nM), indeed induced apoptosis. Supporting a specific effect on PGR by RU 486 and Org 31710, the induced apoptosis was fully reversible by addition of R5020. To the best of our knowledge, the effects of nanomolar concentrations of PGR antagonists on apoptosis and a complete reversal by adding a progestin have not been demonstrated previously in periovulatory rat granulosa cells. The massive apoptosis induced by micromolar concentrations of PGR antagonists was not reversed by R5020, indicating unspecific or toxic effects. Although Org 31710 at 100 nM (as expected) had no effect in immature granulosa cells, there was a modest but significant effect of the micromolar concentrations.
In addition to the classic transcriptional effects of PGR, P4 can act via rapid nongenomic signaling pathways. Such rapid effects can be mediated by the recently characterized membrane progesterone receptor family discovered by Zhu et al. [38, 39] . Comprising three members now named progestin and adipoQ receptor family member (PAQR) 7 (formerly progestin membrane receptor a), PAQR8 (progestin membrane receptor b), and PAQR5 (progestin membrane receptor c), these receptors are involved in diverse reproductive functions in mammals and in other vertebrates [16] . Current understanding of the PAQR family does not, however, include a role in apoptosis regulation, and a functional role for these proteins has not been investigated herein.
In the context of apoptosis, the most notable candidates for rapid responses to P4 are PGRMC1 and SERBP1 proteins. The functions, ligands, and binding partners of PGRMC1 have not been clearly defined, but a proposed hypothetical model states that PGRMC1 functions as a ligand and/or kinase-regulated signaling adapter molecule involved in membrane trafficking [26, 40] . PGRMC1 and SERBP1 have been suggested to control apoptosis in granulosa cells of many developmental stages and have been proposed to provide an explanation as to why P4 can regulate apoptosis in cells in which PGR is not expressed [21, [23] [24] [25] . Therefore, an additional objective herein was to examine the possibility that the effects of PGR antagonists on apoptosis could be mediated indirectly via PGRMC1 and SERBP1.
Progesterone receptor antagonists have been suggested to affect the production of P4 in luteal cells, possibly by decreasing the activity of the key steroidogenic enzyme HSD3B [31] [32] [33] . This decrease in available ligand for P4 membrane receptors has been proposed to explain apoptosis induced by PGR antagonists [21] . In the primary cultured periovulatory granulosa cells used herein, accumulation of P4 in spent medium was indeed decreased after treatment with Org 31710 (100 nM). However, the rather modest decrease in P4 synthesis is not necessarily enough to cause apoptosis, and it could in fact be the result of the increase in apoptosis rather than the cause of apoptosis. When cyanoketone was used to block P4 synthesis, apoptosis was indeed induced concurrently. However, the increase in caspase activity only reached levels comparable to those seen after treatment with PGR antagonists when accumulated P4 was strongly reduced to below 5 nM. Therefore, apoptosis induced by PGR antagonists cannot be explained by inhibition of P4 synthesis alone. Even at the 1 lM concentration of cyanoketone, the increase in apoptosis was fully reversible by addition of R5020 (5 nM), indicating a P4-specific action.
Most important, 5 nM of R5020 was sufficient to fully provide a P4-mediated antiapoptotic response, which is reasonable considering that the dissociation constant (K d ) of R5020 for PGR has been reported to be in the range of 1-4 nM [41, 42] . In fact, specific phosphorylation of PGR can render the receptor even more sensitive to progestins (,1 nM) [43] . In comparison, the reported P4-binding sites of PGRMC1 have K d values of 11 nM and 286 nM for P4 [44] , while affinity for R5020 has not been reported. The PAQR family members have demonstrated K d values of 5 nM for P4, but they have much lower affinity for R5020 and RU 486, with values in the micromolar range at least regarding PAQR7 [16, 45] . It follows that apoptosis induced by cyanoketone-mediated removal of P4 is unlikely mediated by PGRMC1 or by the PAQR family.
The results presented herein (Fig. 4) show that cyanoketone more potently induces apoptosis than Org 31710 or RU 486. These data suggest that the effects of P4 are mediated by other receptors in addition to PGR. However, the additional effect of cyanoketone was surprisingly completely abolished when cotreated with PGR antagonist Org 31710 or RU 486. A possible explanation for this apparent anomaly is that the antiapoptotic effect of PGR antagonists in combination with cyanoketone can be explained by their partial agonistic properties [46] [47] [48] , which become apparent only in the absence of the natural ligand (P4). The effect of cyanoketone could thus be interpreted as the response to a complete lack of PGR signaling, whereas the effect of PGR antagonists is only a partial reduction of the normal PGR response. Partial agonism of RU 486 is mediated only via PGR-B and not via PGR-A [46, 47] and could involve cross talk with other transcription factors, which is often independent of whether the PGR ligand is an agonist or an antagonist [49] [50] [51] [52] . If this theory holds true, it strengthens the hypothesis that PGR is the dominant mediator of P4-regulated apoptosis.
There may be parallel effects of P4 mediated via PGR and via PGRMC1/SERBP1. Studies by Engmann et al. [21] and Peluso et al. [24] have shown that an anti-PGRMC1 antibody specifically detects PGRMC1 protein and that it completely blocks the antiapoptotic effects of P4 in their models. In our hands, this antibody clearly detected a single band of the expected size, demonstrating its functional integrity and protein expression in our model system. The expression of Pgrmc1 and Serbp1 has also been investigated (Friberg et al., unpublished results), including mRNA data from microarray and real-time PCR, in which the levels of both transcripts were high and were unaffected by treatment with Org 31710.
Despite an apparently functional antibody, we saw no induction of apoptosis at any of the concentrations tested. In fact, the degree of apoptosis was decreased to approximately 90% of control values, similar to the effect of preimmunized rabbit serum, indicating an unspecific effect of serum proteins. Similar results were also obtained using immature rat granulosa cells. Although previous studies have reported an antiapoptotic effect of P4 in immature granulosa cells [34] and in SIGCs [35] , addition of P4 in our hands had no effect on caspase activity in immature cells. This was not due to the presence of P4 in the medium, as cyanoketone (in contrast with previous findings [34] ) also failed to induce apoptosis. To summarize, we found no support for a role of PGRMC1 in the regulation of periovulatory or immature granulosa cell apoptosis, as we were able to neither induce apoptosis nor reverse an antiapoptotic effect of P4 using anti-PGRMC1. Most important, our data do not support an effect of P4 in immature granulosa cells, as has previously been suggested [24, 34] .
In conclusion, the present study indicates that PGR is the primary mediator of P4-regulated apoptosis. The following PROGESTERONE CONTROL OF GRANULOSA CELL APOPTOSIS lines of evidence support this conclusion: 1) the reversible induction of apoptosis by nanomolar concentrations of PGR antagonists, 2) the reversal of apoptosis induced by cyanoketone by 5 nM R5020 in relation to reported affinities of R5020 to different P4 receptors, and 3) the ability of PGR antagonists to limit the effectiveness of cyanoketone. In contrast, we were unable to find support for PGRMC1 as a regulator of apoptosis or for P4 as a regulator of immature granulosa cell apoptosis. The role of PGRMC1 in this process is therefore uncertain. This work solidifies the role of P4 as a survival factor in the rat periovulatory interval; however, its biological significance in vivo and its relative importance compared with other survival factors are still to be determined. Based on these data, future studies investigating the cellular events linking P4 to apoptosis in the rat periovulatory interval should concentrate on the transcriptome.
